Navigation Links
VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD
Date:7/1/2009

in children age 6 to 12 years and approved in April 2008 to treat ADHD in adults, is currently available in six dosage strengths of 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg. To date, more than 6 million VYVANSE prescriptions have been filled, bringing the current US market share to over 12 percent based on weekly branded prescription volume. Additionally, Shire has executed agreements with 10 of Shire's top 11 managed care organizations (MCOs) to cover VYVANSE in a preferred formulary position. Approximately 95 percent of prescriptions are approved by health plans at the national average copay of $34.00. These figures are comparable with other ADHD treatment options.

VYVANSE is a therapeutically inactive prodrug, in which d-amphetamine is covalently bonded to l-lysine, and after oral ingestion it is converted to pharmacologically active d-amphetamine. The conversion of VYVANSE to d-amphetamine is not affected by gastrointestinal pH and is unlikely to be affected by alterations in GI transit times.


'/>"/>

Contact: Matthew Cabrey (Shire North America)
484-595-8248
Porter Novelli
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder
2. VYVANSE provided behavior, inattention and math test score improvements in children with ADHD
3. Phase III pivotal results presented of VYVANSE to treat ADHD in adults
4. FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
5. FDA approves additional dosage strengths of Vyvanse
6. Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track
7. VYVANSE trial in adult ADHD demonstrated significant efficacy within 1 week of daily treatment
8. Record Number of Volunteers Provided Free Dental Care to Needy Children in Minnesota
9. Chronic Pain Patients Now Have Hope With Carryover Pain Relief Provided By Repeated Interferential Treatments
10. National Institutes of Health Expands Use of Emergency Notification Services Provided by Send Word Now(TM) Across NIH Campus
11. $5.15 Million Provided to Support Local Health Care Needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Adventist Health System, which is ... Florida Hospital Tampa, Florida Hospital Carrollwood, Florida Hospital ... Pinellas, Florida Hospital Wesley Chapel, Florida Hospital Zephyrhills, ... Heartland Medical Center Lake Placid and Florida Hospital ... Most Wired Hospitals and Health Systems, which is ...
(Date:7/31/2014)... 2014 Hook Your Ex, a system created by ... feel emotionally hungry for their partner, to the point of starvation, ... little trick has been taught to hundreds of men and women ... Hook Your Ex review , Shane Michaels agrees this simple trick ... a breakup a second chance at getting back together with their ...
(Date:7/31/2014)... 31, 2014 United Theological Seminary is ... Anthony Le Donne and Peter J. Bellini. Both began ... to United is a Director of Non-Degree Programs, Mark ... , Anthony Le Donne, Assistant Professor of New Testament, ... teaches New Testament, Second Temple Judaism, and Greek courses. ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Cosmetic Town ... best Plastic Surgeons to consumers considering cosmetic treatments. ... their peers whose goal is to educate prospective patients ... are selected through a validated referral system that helps ... the best in their respective fields. , Cosmetic ...
(Date:7/31/2014)... The VitaSleep FDA cleared anti-snoring device ... an easier breathing capacity by slightly adjusting the position ... can breathe easier and helps reduce or even completely ... it can meet the needs of each individual snorer. ... by actual customer reviews. Johathan R. from Statham ...
Breaking Medicine News(10 mins):Health News:Florida Hospital West Florida Region is Among the Most Wired Hospitals and Health Systems in the United States 2Health News:Hook Your Ex Review by Shane Michaels Exposes Steve Pratt And His New Method For Getting Back With The Ex 2Health News:Growing Seminary Welcomes New Faculty 2Health News:The New Doctors’ Directory, Cosmetic Town Does the Research for Consumers of Plastic Surgeries 2Health News:New Dental Device Reviews to Stop Snoring by VitalSleep 2
... 2011) The Lymphoma Division of the John Theurer Cancer ... the Facebook groups "Hope for Lymphoma" and "Our MCL Family," ... November 12 from 8:30am 3:45pm. The event is ... Lymphoma (MCL) patients and their caregivers coping with this challenging ...
... EDITOR,S PICK: Connexins: providing protection to cells destroyed in ... a lifelong disease characterized by high levels of sugar ... patient,s immune system attacking and destroying the cells in ... blood glucose levels. Surprisingly, little is known about the ...
... , MONDAY, Nov. 7 (HealthDay News) -- People who believe ... it than those who think the rule has some wiggle room, ... a number of human behaviors and actions, including the Arab Spring ... in an upcoming issue of the journal Psychological Science . ...
... be published online Nov. 6 in Nature Medicine , ... that the development of osteoarthritis is in great part driven ... prevailing view attributing the condition to a lifetime of wear ... said William Robinson, MD, PhD, the study,s senior author, of ...
... Ore. After men become fathers for the first time, ... according to a new, 19-year study. Researchers assessed more ... to 31, and examined how men,s crime, tobacco, alcohol, and ... marriage can change a man,s negative behavior, they had not ...
... undergo radical prostatectomy get better results at teaching hospitals ... of an international study led by researchers at Henry ... that teaching hospitals always provide better care than others, ... characteristics that would explain the better results," says Quoc-Dien ...
Cached Medicine News:Health News:John Theurer Cancer Center to host inaugural Mantle Cell Lymphoma Symposium 2Health News:John Theurer Cancer Center to host inaugural Mantle Cell Lymphoma Symposium 3Health News:JCI online early table of contents: Nov. 7, 2011 2Health News:JCI online early table of contents: Nov. 7, 2011 3Health News:JCI online early table of contents: Nov. 7, 2011 4Health News:JCI online early table of contents: Nov. 7, 2011 5Health News:JCI online early table of contents: Nov. 7, 2011 6Health News:People Seem More Likely to Follow Rules They Can't Beat 2Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 2Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 3Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 4Health News:Fatherhood can help change a man's bad habits 2Health News:Prostate cancer surgery better at teaching hospitals 2
(Date:7/31/2014)... NEW YORK and VIENNA , ... today at a press conference in New York ... of PD01A, a vaccine against Parkinson,s disease. PD01A is the ... target, to enter clinical testing. The Michael J. ... a $ 1.5 million grant, and presented at the press ...
(Date:7/31/2014)... LONDON , July 31, 2014 genae, ... medical industries, announced today the incorporation of genae UK in ... has one of the largest medical device markets in ... and it is projected to increase by a CAGR of 6.0% ... 2012, equal to 9.5% of GDP. Despite recessionary pressures, market growth ...
(Date:7/31/2014)... 2014 Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics ... a conference call on Thursday, August 14, 2014, at 4:30 ... ended June 30, 2014. Financial results will be issued in ... Chairman, President and CEO James LaFrance will host ... Date: Thursday, August 14, 2014 Time: 4:30 p.m. Eastern ...
Breaking Medicine Technology:First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4genae Opens Offices in London 2Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2
... Oct. 14 Cephalon, Inc. (Nasdaq: CEPH ... Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) ... Administration (FDA).  The GABITRIL REMS consists of a Medication ... with the use of GABITRIL.  The implementation of the ...
... SMA ), a leading independent provider of products ... announced today that it will release third quarter 2010 financial ... market opens on Thursday, November 4, 2010. Symmetry Medical will ... Thursday, November 4, 2010. A live Web ...
Cached Medicine Technology:Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL 2Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL 3Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL 4Symmetry Medical to Report Third Quarter 2010 Financial Results on November 4, 2010 2
Cushing Little Joker periosteal elevators, solid handle, blade width 1/4" (6 mm), length 7 1/2" (191 mm)....
Molt 9 periosteal elevators....
Alexander periosteal elevators....
Lambotte periosteal elevators....
Medicine Products: